by admin | May 27, 2014 | Latest News
Expanded SAB will oversee development of EMA401, Company’s lead program for treating chronic pain. Melbourne, Australia – Spinifex Pharmaceuticals, a pain drug development company, today announces that three internationally acclaimed scientists in...
by admin | May 2, 2014 | Latest News
Uniseed portfolio company Fibrotech Therapeutics Pty Ltd, developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that it has reached an agreement with Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty...
by admin | May 2, 2014 | Latest News
The company Remains Committed to Bringing Moxduo® to Market. QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Dr. John Holaday has stepped down as Managing Director and Chief Executive Officer. The Company’s Board of Directors has appointed Dr....
Recent Comments